TY  - JOUR
AU  - Cerezuela-Fuentes, Pablo
AU  - Gonzalez-Cao, Maria
AU  - Puertolas, Teresa
AU  - Manzano, Jose Luis
AU  - Maldonado, Cayetana
AU  - Yelamos, Oriol
AU  - Berciano-Guerrero, Miguel A
AU  - Martin-Liberal, Juan
AU  - Muñoz-Couselo, Eva
AU  - Espinosa, Enrique
AU  - Drozdowskyj, Ana
AU  - Berrocal, Alfonso
AU  - Soria, Ainara
AU  - Marquez-Rodas, Ivan
AU  - Martin-Algarra, Salvador
AU  - Quindos, Maria
AU  - Puig, Susana
PY  - 2024
DO  - 10.1007/s12094-024-03583-5
SN  - 1699-048X
UR  - https://hdl.handle.net/10668/28505
T2  - Clinical and Translational Oncology
AB  - Background Novel and highly efective drugs for non-melanoma skin cancer (NMSC) improve patient outcomes, but their high cost strains healthcare systems. Spain’s decentralized public health system, managed by 17 autonomous communities (AaCc), raises...
LA  - en
PB  - Springer
KW  - Access
KW  - Innovative therapies
KW  - Non-melanoma skin cancer
KW  - Cross-Sectional Studies
KW  - Public Health
KW  - Antineoplastic Agents
KW  - Carcinoma, Basal Cell
KW  - Skin Neoplasms
KW  - Physicians
KW  - Delivery of Health Care
TI  - Access to systemic treatment of non-melanoma skin cancer in Spain: a survey analysis.
TY  - research article
VL  - 27
ER  -